Cargando…

Adenovirus vector-based vaccines as forefront approaches in fighting the battle against flaviviruses

Flaviviruses are arthropod-borne viruses (arboviruses) that have been recently considered among the significant public health problems in defined geographical regions. In this line, there have been vaccines approved for some flaviviruses including dengue virus (DENV), Japanese encephalitis virus (JE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shoushtari, Mohammad, Roohvand, Farzin, Salehi-Vaziri, Mostafa, Arashkia, Arash, Bakhshi, Hasan, Azadmanesh, Kayhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Novel Vaccines – Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481145/ https://www.ncbi.nlm.nih.gov/pubmed/35714271 http://dx.doi.org/10.1080/21645515.2022.2079323

Ejemplares similares

Isolation, cloning, and expression of E. coli BirA gene for biotinylation applications
por: Etemadzadeh, Mohammad Hossein, et al.
Publicado: (2015)

Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy
por: Palamenghi, Lorenzo, et al.
Publicado: (2020)

A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice
por: Motavalli Khiavi, Farhad, et al.
Publicado: (2018)

Acceptability for the influenza virus vector COVID-19 vaccine for intranasal spray: A cross-sectional survey in Beijing, China
por: Ma, Yuan, et al.
Publicado: (2023)

Immunization of mice by a multimeric L2-based linear epitope (17-36) from HPV type 16/18 induced cross reactive neutralizing antibodies
por: Khiavi, Farhad Motavalli, et al.
Publicado: (2017)

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization
por: Maxfield, Lori F., et al.
Publicado: (2015)

Expression of a biotin acceptor peptide-containing protein with potential incorporation on the lentiviral envelope as a viral surface engineering platform
por: Etemadzadeh, Mohammad Hossein, et al.
Publicado: (2015)

A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults
por: Russell, Kevin L., et al.
Publicado: (2022)

Establishment of the 1st Chinese national standard for CA6 neutralizing antibody
por: Wang, Yiping, et al.
Publicado: (2023)

A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal
por: Chaudhary, Shipra, et al.
Publicado: (2023)

The applications of animal models in phage therapy: An update
por: Mehmood Khan, Fazal, et al.
Publicado: (2023)

Immunogenicity and safety of the non-typable Haemophilus influenzae–Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial
por: Galgani, Ilaria, et al.
Publicado: (2023)

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study
por: Huang, Xiaoyuan, et al.
Publicado: (2023)

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial
por: López, Pio, et al.
Publicado: (2023)

Preclinical safety evaluation of a bivalent inactivated EV71-CA16 vaccine in mice immunized intradermally
por: Liao, Yun, et al.
Publicado: (2023)

Analysis and prediction of the incidence and prevalence trends of gonorrhea in China
por: Chen, Xueya, et al.
Publicado: (2023)

An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-life
por: Patel, Sanjay S., et al.
Publicado: (2023)

Advancements in the development of nucleic acid vaccines for syphilis prevention and control
por: Li, Sijia, et al.
Publicado: (2023)

Challenges in development of vaccines directed toward antimicrobial resistant bacterial species
por: Brazzoli, Michela, et al.
Publicado: (2023)

The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options
por: Beig Parikhani, Arezoo, et al.
Publicado: (2021)

Modifying oncolytic virotherapy to overcome the barrier of the hypoxic tumor microenvironment. Where do we stand?
por: Shayan, Sara, et al.
Publicado: (2022)

Construction of Various γ34.5 Deleted Fluorescent-Expressing Oncolytic herpes Simplex type 1 (oHSV) for Generation and Isolation of HSV-Based Vectors
por: Abdoli, Shahriyar, et al.
Publicado: (2017)

In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines
por: Shayan, Sara, et al.
Publicado: (2023)

Fiber manipulation and post-assembly nanobody conjugation for adenoviral vector retargeting through SpyTag-SpyCatcher protein ligation
por: Kadkhodazadeh, Maryam, et al.
Publicado: (2022)

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
por: Green, C, et al.
Publicado: (2023)

Immune camouflage: Relevance to vaccines and human immunology
por: De Groot, Anne S, et al.
Publicado: (2014)

Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches
por: Absalon, Judith, et al.
Publicado: (2022)

A strategic model for developing vaccines against neglected diseases: An example of industry collaboration for sustainable development
por: Berlanda Scorza, Francesco, et al.
Publicado: (2022)

IFN-α(2b) reduces released particles of Human T-lymphotropic Virus-I from HTLV-I transformed cell line
por: Hartoonian, Christine, et al.
Publicado: (2011)

Replicating Single-Cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses
por: Crosby, Catherine M., et al.
Publicado: (2017)

The β‐domain of streptokinase affects several functionalities, including specific/proteolytic activity kinetics
por: Rafipour, Maryam, et al.
Publicado: (2019)

Contribution of Streptokinase-Domains from Groups G and A (SK2a) Streptococci in Amidolytic/Proteolytic Activities and Fibrin-Dependent Plasminogen Activation: A Domain-Exchange Study
por: Rafipour, Maryam, et al.
Publicado: (2020)

Mechanism through Which Retrocyclin Targets Flavivirus Multiplication
por: Jia, Xiaoying, et al.
Publicado: (2021)

Vaccination at the forefront of the fight against hepatitis B and C
por: El-Sayed, Manal H., et al.
Publicado: (2021)

Correlative outcomes of maternal immunization against RSV in cotton rats
por: Blanco, Jorge C. G., et al.
Publicado: (2022)

Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model
por: Dhakal, Santosh, et al.
Publicado: (2021)

Vaccine hesitancy: the next challenge in the fight against COVID-19
por: Dror, Amiel A., et al.
Publicado: (2020)

Adenovirus Vector Vaccination Impacts NK Cell Rheostat Function following Lymphocytic Choriomeningitis Virus Infection
por: Blass, Eryn, et al.
Publicado: (2018)

Isolation of novel simian adenoviruses from macaques for development of a vector for human gene therapy and vaccines
por: Lan, Wendong, et al.
Publicado: (2023)

Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope
por: Mashhadi Abolghasem Shirazi, Maryam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_glj4a3b28g1u6l6e73rrrn8sfi